Member Info for bluerose

This stock won’t start trading until January 6. But RM2, which makes the pallets used in their billions by retailers and many other businesses every day, looks like it has a bright future. Rather than traditional wooden pallets, RM2 makes, sells and rents its BLOCKPal version made out of glass fibre and resin composite. The advantage is that they are more durable, less likely to damage goods, easier to make in bespoke shapes and can easily be fitted with tracking devices to improve logistics. They also help firms meet environmental sustainability targets. RM2 produces 1m pallets a year at the moment and says it can get to 2.5m next year with the £137.2m proceeds of its float, and 7m by 2015. Management thinks US customers want to extend contracts to European and Asian subsidiaries. They also think RM2 will not need to raise equity again. Sir Stuart Rose and former Diageo boss Paul Walsh are on the board. It is chaired by Ian Molson, former deputy chairman of the Canadian brewing giant. *** It does say 1M *** Read more: http://www.thisismoney.co.uk/money/markets/article-2530313/Top-share-tips-2014-Daily-Mail-City-team.html#ixzz2qbNzqEwJ Follow us: @MailOnline on Twitter | DailyMail on Facebook

Like you I can see nothing wrong with this company. People are not realising that this is a "new listing ". Given chance , even one month , I am sure that some news will be given

Mon, 13th Jan 2014 14:48 RNS Number : 5277X RM2 International SA 13 January 2014 RM2 International S.A. Director / PDMR Shareholding RM2 International S.A. ("RM2" or the "Company") announces that it was notified on 10 January 2014 that The Swiftsure Trust, a discretionary trust of which the principal beneficiaries are the children of Ian Molson, Chairman of RM2, acquired 500,000 ordinary shares in the company ("Ordinary Shares") at a price of 93.58 pence per ordinary share on that date. Following this transaction, Mr Molson is interested in a total of 4,451,340 Ordinary Shares, representing approximately 1.4 per cent. of the existing issued share capital of the Company.

RM2′s strong IPO debut Pallet manufacturer and rental group RM2 International (RM2:AIM) makes an impressive stockmarket debut with a 20% rise to 105.5p. The group has raised £137.2 million to help increase its production capacity and have a pool of pallets to rent to customers in such sectors as food, drink, pharmaceuticals and technology. RM2 has developed a new form of pallets that it claims are more robust and last longer than traditional wood products. There’s big names on the board including former Marks & Spencer (MKS) boss Stuart Rose, Paul Walsh who is ex-chief executive of Diageo (DGE) and incoming chairman of catering group Compass (CPG). RM2′s chief executive John Walsh (pictured above) is a former investment banker. We published a swot analysis on the stock and fleshed out its growth plans in last week’s issue of Shares, saying to buy the shares on day one. We like the company’s strong cash position, big customer names and well-connected board. As we highlight in the article, longer-term this could be an attractive dividend stock because of the significant cash flow potential from pallet rental agreements. You’ll need to be a subscriber to read the full story. Those not already signed up can get an introductory offer via this link. The business raised cash at 88p. Today’s share price rise means RM2 is now valued at £334 million. The Daily Mail has picked RM2 as one of its top share tips for 2014. Date: 06-01-2014 09:32

Pallet of good returns By Rob Davies . This stock won’t start trading until January 6. But RM2, which makes the pallets used in their billions by retailers and many other businesses every day, looks like it has a bright future. Rather than traditional wooden pallets, RM2 makes, sells and rents its BLOCKPal version made out of glass fibre and resin composite. The advantage is that they are more durable, less likely to damage goods, easier to make in bespoke shapes and can easily be fitted with tracking devices to improve logistics. They also help firms meet environmental sustainability targets. RM2 produces 1m pallets a year at the moment and says it can get to 2.5m next year with the £137.2m proceeds of its float, and 7m by 2015. Management thinks US customers want to extend contracts to European and Asian subsidiaries. They also think RM2 will not need to raise equity again. Sir Stuart Rose and former Diageo boss Paul Walsh are on the board. It is chaired by Ian Molson, former deputy chairman of the Canadian brewing giant. Read more: http://www.thisismoney.co.uk/money/markets/article-2530313/Top-share-tips-2014-Daily-Mail-City-team.html#ixzz2poN24A52 Follow us: @MailOnline on Twitter | DailyMail on Facebook

Give it time. This is only the second trading day !! RM2 have a product which is proven to work . and is better than its competitors. It is not hoping to find customers RM2 has them already.

Ride the wave at SeaEnergy By Ian Lyall My tip this year is a clever tech company masquerading as an oil services firm. SeaEnergy has a chequered history, but in Return to Scene, a company bought in August 2012, it is onto a real winner.Its 360-degree photographic technology was developed for crime scene management, but is being deployed on remote North Sea oil and gas rigs. SeaEnergy is no jam-tomorrow story: it has a list of top notch clients, including BP, Chevron and Total. And it is predicted to have broken even in 2013 and will make operating profits of around £2.5m this year. That’s not bad for a group valued at£17m currently Read more: http://www.thisismoney.co.uk/money/markets/article-2530313/Top-share-tips-2014-Daily-Mail-City-team.html#ixzz2pjJomWxL Follow us: @MailOnline on Twitter | DailyMail on Facebook

Which changed into a sea of blue !!

Good luck if you are in !

What is going on here ??

What do these trades of 1 ,8,14 etc shares mean. Who would sell this small amount of shares ?

There must be a reason why the BOD felt the need to do this consolidation. It would not have been done just to have a price change. The Germans know how to make their companies work for them and we will be given the real reason in due course.

22-Apr-13 ............Canaccord Genuity Buy 39.00 ........................39.00 ................................Reiteration

,” N+1 Singer Silence Therapeutics is identified by the broker as a developer with a particularly novel technology platform. “The company’s lead programme (Atu027) has generated good safety data in Phase I trials and recently entered Phase Ib/lla trials in pancreatic cancer, with a second indication (most likely head & neck cancer) expected to follow in Q1 2014,” N+1 Singer notes. The recent raising of funds leaves the company well placed to make progress with its promising clinical trials programme, and could lead to a crystallisation of its siRNA technology through partnering deals, the broker suggested

Forgot to add that it does not mean that it will not list on AIM but that it might have a dual listing.

Do not forget that German money is in control here, and the Germans know a thing or two on how to manage their companies. Do not forget what the finance director said ............... Tim Freeborn suggests the market is not picking up on the potential of the company’s ‘gene silencing’ technology. New York-listed Alnylam Pharmaceuticals, which has a market value of almost US$1.5bn, is one of Silence’s closest peers, targeting liver cancer. Freeborn says Silence, whose platform technologies can be used to turn off faulty genes, has the potential to tackle a wider array of diseases than its American peer yet is valued at just US$50mln (£33mln). Freeborn said “These other companies have been spending hundreds of millions of dollars a year, year after year, and Silence’s burn is a fraction of what they are spending unquote. Could it be that this consolidation is the first step towards a Nasdaq listing ? The new share price will make that possible. SLN will command a much higher share price if that had to happen.

10 April 2013 Antisoma plc ("Antisoma") Placing Agreement with Silence Therapeutics plc ("SLN") The Directors announce that on 9 April 2013, Antisoma entered into a placing agreement to subscribe for 2,000,000 new ordinary shares in SLN under SLN's proposal to raise approximately £19.0m before expenses by means of a placing of 9,512,500 new ordinary shares at an issue price of 200p per share. As announced by SLN on 10 April 2013, SLN intends to effect a share capital consolidation on the basis of 1 Consolidated Ordinary Share for every 50 Existing Ordinary Shares held. Immediately following the share consolidation, the placing of 9,512,500 new ordinary shares is expected to occur. Both the share consolidation and the placing of new ordinary shares are conditional upon approval by SLN shareholders at a General Meeting that will be held on 29 April 2013. Antisoma's agreement with SLN to subscribe for 2,000,000 new ordinary at 200p per share represents a total commitment of £4 million. The 9,512,500 new SLN ordinary shares would represent approximately 20.2 per cent. of the Enlarged Share Capital of SLN. Following the placing, Antisoma will have an interest over approximately 4.25 per cent. of the issued share capital of SLN. .

Gemfields' assets have significant potential "if appropriately utilised", JPM asserts By John Harrington April 09 2013, 12:53pm The potential ban on selling outside of Zambia creates uncertainty, JP Morgan says. The government decree that gemstones produced in Zambia should also be sold in Zambia could prove an own goal, JP Morgan’s research suggests. The Zambian government owns a 25% stake in the Kagem emerald mine in Zambia, with London-listed Gemfields (LON:GEM) owning the remainder. If brought into law, the decree would, in JP Morgan’s opinion, restrict Gemfields' ability to maximise the revenue generated from the Kagem emerald mine. The heavyweight US broker notes that, since taking over control of the Kagem mine in 2009, Gemfields has hosted 11 emerald auctions in places ranging from Jaipur, Johannesburg, London to Singapore. “The three most recent auctions of higher quality gems have been held in Singapore and have generated much higher revenues than those held elsewhere,” JP Morgan (JPM) notes. “The average proceeds from higher quality auctions in Singapore have been US$28.2m, compared to an average of US$9.7m for higher quality auctions held elsewhere. Although part of the improvement is a result of the better quality of gems on sale, as well as increased global demand, we believe the location of the auctions in Singapore, readily accessible for the key purchasers, has also been a factor,” JPM asserts. Gemfields will be holding an auction in Lusaka, the capital of Zambia, later this month, on April 15-19. In JPM’s view, holding all future auctions of Gemfields’ Zambian output to Lusaka runs the risk that demand could be affected, not to mention the competitive position of Gemfields’ emerald in comparison to those from Colombia and elsewhere. “The government of Zambia is a 25% shareholder in Kagem and so would presumably want to consider the impact of any changes on the value of its investment as well as the tax remittance currently being generated,” JPM speculates. At this stage, the company expects the next auction to take place, as planned, in Singapore in June. We expect Gemfields to work with the government of Zambia to establish what restrictions, if any, will be applied to its activities before then,” the broker added. In the meantime, JP Morgan is sticking with its ‘neutral’ stance on the shares. In the broker’s view, “the assets controlled by Gemfields have the potential, if appropriately utilised, to create significant shareholder value

Not good news, but things might change . With the Faberge deal GEM has opened up new venues. It is always best to remain calm in times like this. The worse one could do is sell in panic.

What is going on? Two large BUY deals both at 16:23 One for £11.38k and another for £11.50k .The share price closed up at 4.60.